Moreover, we disclosed that it is sTNFα and not tmTNFα that drives MUC4 expression; we observed that HER2+MUC4+ breast cancer cells and tumors were also sensitized to trastuzumab in combination with INB03 [165]. This evidence concerns the gene ERBB2 and breast cancer.